KATHRYN E FALBERG Insider Trading $LIFE aTYR PHARMA INC
Get free email notifications about insider trading for KATHRYN E FALBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KATHRYN E FALBERG. KATHRYN E FALBERG is Director in HUMAN GENOME SCIENCES INC ($HGSI) and Director in MEDIVATION, INC. ($MDVN) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and Director in aTYR PHARMA INC ($LIFE) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and Director in Aimmune Therapeutics, Inc. ($AIMT) and Director in Axovant Sciences Ltd. ($AXON) and Director in Trade Desk, Inc. ($TTD) and Director in UroGen Pharma Ltd. ($URGN) and Director in Arcus Biosciences, Inc. ($RCUS) and Director in Nuvation Bio Inc. ($PANA).
KATHRYN E FALBERG in aTYR PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KATHRYN E FALBERG: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 26 2016
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KATHRYN E FALBERG in aTYR PHARMA INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AIMT, RCUS, LIFE, BMRN, GYHT, HGSI, MDVN, NUVB, AXON, TTD, TCDA, URGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 26 2016 | LIFE | aTYR PHARMA INC | FALBERG KATHRYN E | Director | Option Exercise | A | 3.33 | 18,000 | 59,940 | 18,000 | |
| Jan 29 2016 | LIFE | aTYR PHARMA INC | FALBERG KATHRYN E | Director | Option Exercise | A | 6.14 | 19,428 | 119,288 | 19,428 | |
| Jul 10 2015 | LIFE | aTYR PHARMA INC | FALBERG KATHRYN E | Director | Option Exercise | A | 14.96 | 6,286 | 94,039 | 6,286 |
Page: 1